Skip to main content

Moderna says it plans to expand Covid vaccine trial for kids 5 to 11, will seek FDA OK as early as year end

Moderna confirmed to CNBC on Monday it plans to expand the size of its clinical trial testing its Covid-19 vaccine in kids ages 5 to 11.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.